Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-1.95%
|
$12,600
$35.61 P/Share
|
|
Dec 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
710
+3.7%
|
-
|
|
Dec 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-0.42%
|
$4,830
$35.61 P/Share
|
|
Dec 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+0.79%
|
-
|
|
Dec 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-0.29%
|
$5,635
$35.61 P/Share
|
|
Dec 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
316
+0.57%
|
-
|
|
Nov 30
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.51%
|
-
|
|
Nov 18
2024
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
7,000
-28.29%
|
$203,000
$29.25 P/Share
|
|
Nov 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.5%
|
-
|
|
Nov 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+4.77%
|
-
|
|
Nov 13
2024
|
Meghan V. Joyce Director |
SELL
Open market or private sale
|
Direct |
2,896
-27.47%
|
$83,984
$29.9 P/Share
|
|
Nov 12
2024
|
Ian T Clark Director |
BUY
Other acquisition or disposition
|
Indirect |
8,435
+50.0%
|
-
|
|
Nov 12
2024
|
Ian T Clark Director |
SELL
Other acquisition or disposition
|
Direct |
8,435
-100.0%
|
-
|
|
Nov 12
2024
|
Ian T Clark Director |
SELL
Open market or private sale
|
Direct |
8,318
-26.31%
|
$241,222
$29.48 P/Share
|
|
Nov 12
2024
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,076
+6.04%
|
$4,304
$4.18 P/Share
|
|
Nov 04
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,945
-8.3%
|
$113,735
$23.6 P/Share
|
|
Nov 04
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,756
+14.07%
|
-
|
|
Nov 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.62%
|
-
|
|
Oct 31
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.53%
|
-
|
|
Oct 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.51%
|
-
|
|
Oct 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+5.0%
|
-
|
|
Oct 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.63%
|
-
|
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,824
-10.4%
|
$84,128
$22.12 P/Share
|
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,543
+9.14%
|
-
|
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,009
-7.45%
|
$88,198
$22.12 P/Share
|
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,908
+6.82%
|
-
|
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,200
-15.29%
|
$92,400
$22.12 P/Share
|
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,284
+13.44%
|
-
|
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,620
-10.32%
|
$79,640
$22.12 P/Share
|
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,498
+11.06%
|
-
|
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,980
-10.75%
|
$65,560
$22.12 P/Share
|
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,877
+9.88%
|
-
|
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,162
-14.74%
|
$91,564
$22.12 P/Share
|
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,211
+22.53%
|
-
|
|
Sep 30
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,809
-0.26%
|
$127,798
$22.94 P/Share
|
|
Sep 30
2024
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+0.52%
|
-
|
|
Sep 30
2024
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+1.55%
|
-
|
|
Sep 30
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,809
-0.25%
|
$127,798
$22.94 P/Share
|
|
Sep 30
2024
|
Helmy Eltoukhy Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,461
+0.49%
|
-
|
|
Sep 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
249
+5.25%
|
-
|
|
Sep 15
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-2.2%
|
$15,522
$26.79 P/Share
|
|
Sep 15
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+4.91%
|
-
|
|
Sep 15
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
324
-1.46%
|
$8,424
$26.79 P/Share
|
|
Sep 15
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
638
+2.8%
|
-
|
|
Sep 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
68
+0.5%
|
-
|
|
Sep 15
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-1.74%
|
$13,442
$26.79 P/Share
|
|
Sep 15
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,019
+3.31%
|
-
|
|
Sep 15
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-7.65%
|
$43,134
$26.79 P/Share
|
|
Sep 15
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+7.25%
|
-
|
|
Sep 15
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-3.57%
|
$18,486
$26.79 P/Share
|